Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

Not a done deal by any means, but the new proposed healthcare bill just released in the Senate today includes $4.95 billion a year in funding for treatment (counseling and MAT) for the next nine years ($45 billion total).

I think the whole US buprenorphine market is around $2.5 billion, so this would seem to be huge to me, but the market shrugs.

Obama's 21st Century Cares Act passed in November 2016 had $1 billion in opioid epidemic funding over two years, but a lot of that is going to government infrastructure, education etc. None of it goes to the states to actually treat people.

The first version of the Senate bill included $2 billion to the states over 2 years.

This second version is nearly $5 billion a year over nine years, and is aimed at treatment.

http://www.marketwatch.com/story/opioid-abuse-takes-center-stage-from-senate-health-bill-to-yellen-hearing-2017-07-13